Sign inGet started

Venrock Partners, L.P.

Insider CIK 1305239 · AKAO 10% owner · QTNA 10% owner · ANAC 10% owner · BLPH 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BLPH Bellerophon Therapeutics, S Sale2019-10-282019-10-28333,010$0.44 $146.5K6,435,173SEC↗
BLPH Bellerophon Therapeutics, S Sale2019-10-252019-10-2856,242$0.45 $25.3K6,768,183SEC↗
BLPH Bellerophon Therapeutics, S Sale2019-10-242019-10-28704,595$0.50 $352.3K6,824,425SEC↗
BLPH Bellerophon Therapeutics, P Buy2019-01-232019-03-14142,857$0.70 $100.0K7,529,020SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-172018-09-1760,000$1.18 $70.8K7,386,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-142018-09-1775,000$1.23 $92.3K7,326,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-132018-09-1775,000$1.19 $89.3K7,251,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-122018-09-1275,000$1.15 $86.3K7,176,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-112018-09-12200,000$1.14 $228.0K7,101,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-102018-09-12200,000$1.22 $244.0K6,901,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-072018-09-0760,000$0.90 $54.0K6,701,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-062018-09-0750,000$0.84 $42.0K6,641,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-09-052018-09-0750,000$0.85 $42.5K6,591,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-08-162018-08-1666,393$0.65 $43.2K6,541,163SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-08-152018-08-16272,000$0.65 $176.8K6,474,770SEC↗
BLPH Bellerophon Therapeutics, P Buy2018-08-142018-08-16190,977$0.65 $124.1K6,202,770SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion deriv2016-11-022016-11-04383,634— $00SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion deriv2016-11-022016-11-0460,551— $00SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion deriv2016-11-022016-11-04469,779— $00SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion deriv2016-11-022016-11-04805,625— $00SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion deriv2016-11-022016-11-0494,321— $00SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion deriv2016-11-022016-11-0471,744— $00SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion deriv2016-11-022016-11-04322,411— $00SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion2016-11-022016-11-0460,551— $02,653,269SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion2016-11-022016-11-04383,634— $02,592,718SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion2016-11-022016-11-04608,340— $0608,340SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion2016-11-022016-11-04805,625— $01,739,305SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion2016-11-022016-11-04186,644— $0933,680SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion2016-11-022016-11-04138,696— $0747,036SEC↗
QTNA QUANTENNA COMMUNICATIONS I C Conversion2016-11-022016-11-04469,779— $02,209,084SEC↗
AKAO Achaogen Inc C Conversion deriv2014-03-172014-03-17382,913— $00SEC↗
AKAO Achaogen Inc C Conversion deriv2014-03-172014-03-17725,873— $00SEC↗
AKAO Achaogen Inc C Conversion deriv2014-03-172014-03-17223,440— $00SEC↗
AKAO Achaogen Inc C Conversion deriv2014-03-172014-03-17296,981— $00SEC↗
AKAO Achaogen Inc C Conversion2014-03-172014-03-17725,873— $01,363,548SEC↗
AKAO Achaogen Inc C Conversion2014-03-172014-03-17340,797— $0340,797SEC↗
AKAO Achaogen Inc C Conversion2014-03-172014-03-17296,878— $0637,675SEC↗
AKAO Achaogen Inc C Conversion2014-03-172014-03-17382,913— $01,746,461SEC↗
ANAC Anacor Pharmaceuticals, In S Sale2013-11-152013-11-19150,000$14.06 $2.11M3,575,535SEC↗
ANAC Anacor Pharmaceuticals Inc S Sale2012-09-202012-09-2419,273$6.30 $121.4K3,725,535SEC↗
ANAC Anacor Pharmaceuticals Inc S Sale2012-09-142012-09-1835,000$6.51 $227.8K3,744,808SEC↗
ANAC Anacor Pharmaceuticals Inc S Sale2012-09-132012-09-1315,000$6.56 $98.4K3,779,808SEC↗
ANAC Anacor Pharmaceuticals Inc S Sale2012-09-112012-09-1310,177$6.64 $67.6K3,794,808SEC↗
ANAC Anacor Pharmaceuticals Inc J Other2012-07-022012-07-05900,000— $03,725,535SEC↗
ANAC Anacor Pharmaceuticals Inc J Other2012-07-022012-07-0579,450— $03,804,985SEC↗